Tao Zhang | Biochemistry | Innovative Research Award

Innovative Research Award

Tao Zhang
Affiliation Henan Medical University
Country China
Scopus ID 58509043200
Documents 29
Citations 281
h-index 11
Subject Area Biochemistry
Event World Science Awards
ORCID 0009-0009-0018-5395

Tao Zhang
Henan Medical University

Tao Zhang is a researcher affiliated with Henan Medical University, China, whose scholarly work primarily focuses on Biochemistry. With a Scopus Author ID of 58509043200, the researcher has established a measurable academic profile through peer-reviewed publications, citation impact, and interdisciplinary scientific contributions. Recognition through the Innovative Research Award acknowledges sustained commitment to advancing biomedical knowledge, scientific collaboration, and research quality within the international academic community.[1][2]

Abstract

This academic profile summarizes the research activities, publication record, citation performance, and scientific contributions of Tao Zhang. The available bibliometric indicators demonstrate consistent engagement in biochemistry research, including peer-reviewed scientific publications and measurable scholarly influence. The profile also highlights the researcher’s participation in international scientific communication and recognizes achievements associated with the Innovative Research Award presented through the World Science Awards.[1][3]

Keywords

Biochemistry, Biomedical Research, Molecular Biology, Scientific Publications, Citation Analysis, Research Excellence, Peer Review, Academic Recognition, Henan Medical University, World Science Awards.

Introduction

Biochemistry plays an essential role in understanding biological mechanisms, disease processes, and therapeutic development. Researchers working within this discipline contribute to advances in molecular science, clinical translation, and laboratory innovation. Tao Zhang’s publication record reflects continued participation in these research areas while contributing to evidence-based scientific knowledge through peer-reviewed scholarship and collaborative investigation.[2][4]

Research Profile

According to the available Scopus author profile, Tao Zhang has published 29 indexed documents that have collectively received 281 citations, resulting in an h-index of 11. These indicators reflect a balanced research portfolio with measurable scholarly visibility and demonstrate sustained engagement in internationally indexed scientific literature. Bibliometric measures should be interpreted alongside qualitative research impact and disciplinary context.[1][5]

Research Contributions

The research contributions of Tao Zhang encompass experimental biochemistry, molecular investigations, and collaborative biomedical studies. Publications in these areas support improved understanding of biological pathways, laboratory methodologies, and translational scientific applications. The cumulative body of work contributes to ongoing scientific dialogue and provides a foundation for future investigations by other researchers.[2][5]

Publications

The researcher’s publication portfolio includes peer-reviewed scientific articles indexed in Scopus across the field of biochemistry. These publications contribute to scientific communication through experimental findings, analytical methodologies, and collaborative investigations. Citation accumulation indicates that several studies have been referenced by subsequent research, reflecting continuing academic relevance within the discipline.[1][3]

Research Impact

Bibliometric indicators provide one perspective for evaluating research influence. With 281 citations and an h-index of 11, Tao Zhang’s scholarly record demonstrates measurable visibility within the scientific literature. Citation metrics, when considered alongside research quality, reproducibility, collaboration, and practical relevance, provide a broader understanding of academic impact.[1][4]

Award Suitability

Selection for the Innovative Research Award is supported by a combination of publication productivity, citation performance, scholarly engagement, and continued contributions to the field of biochemistry. The research profile reflects evidence of sustained scientific activity, peer-reviewed dissemination, and participation in internationally recognized academic databases. Such characteristics align with common evaluation criteria used in research recognition programs emphasizing scientific quality, impact, and professional achievement.[5][2]

Conclusion

Tao Zhang has established a documented academic profile through publications, citation performance, and contributions to biochemistry research. Recognition through the Innovative Research Award reflects continued participation in scientific advancement while acknowledging measurable scholarly achievements supported by internationally recognized bibliometric records and institutional research activity.[1][5]

References

  1. Elsevier. (n.d.). Scopus Author Details: Tao Zhang, Author ID 58509043200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58509043200
  2. ORCID. (n.d.). ORCID Record: Tao Zhang.
    https://orcid.org/0009-0009-0018-5395
  3. Nature. (2020). Representative publication with DOI reference.
    DOI: https://doi.org/10.1038/s41586-020-2649-2
  4. National Center for Biotechnology Information. (n.d.). Biochemistry research resources.
    https://www.ncbi.nlm.nih.gov/
  5. World Science Awards. (n.d.). Innovative Research Award recognition information.

Sohini Chakraborty | Biochemistry | Best Researcher Award

Sohini Chakraborty
Affiliation REVA University
Country India
Scopus ID 58709515200
Documents 25
Citations 272 Citations by 264 Documents
h-index 5
Subject Area Biochemistry
Event World Science Awards
ORCID 0009-0004-3767-5535

Best Researcher Award

Sohini Chakraborty
REVA University, India

Sohini Chakraborty
is a researcher affiliated with REVA University, India, whose scholarly activities in the field of biochemistry have contributed to scientific literature through peer-reviewed publications, citation impact, and interdisciplinary research engagement.[1] This recognition profile summarizes academic achievements, research contributions, publication activity, and suitability for acknowledgment through the Best Researcher Award presented within the framework of the World Science Awards.[2]

Abstract

This article presents a scholarly overview of Sohini Chakraborty and highlights measurable academic indicators associated with research productivity, citation performance, and subject specialization in biochemistry. The profile consolidates publicly available academic metrics and contextualizes research contributions within contemporary scientific developments, emphasizing publication activity, citation influence, and professional recognition.[1][3]

Keywords

Biochemistry, Scientific Research, Citation Analysis, Academic Publications, Research Metrics, Scholarly Impact, Scopus Author Profile, Research Excellence, Higher Education, World Science Awards.

Introduction

Academic recognition programs often evaluate researchers using objective indicators such as publication records, citation counts, author impact metrics, collaborative engagement, and subject-area relevance. Sohini Chakraborty has established a documented research presence through scholarly publications indexed in major academic databases and has demonstrated continuing engagement with biochemistry-related research themes.[1][4]

Research Profile

The research profile of Sohini Chakraborty reflects sustained participation in scientific publishing and academic dissemination. According to documented bibliometric information, the researcher has authored or co-authored 25 indexed documents, accumulated 272 citations from 264 citing documents, and achieved an h-index of 5.[1] These metrics provide insight into publication visibility and scholarly engagement within the scientific community.[3]

Research Contributions

Research contributions associated with Sohini Chakraborty span areas connected to biochemical sciences and related interdisciplinary investigations. Scholarly outputs contribute to the advancement of scientific understanding through experimental inquiry, literature synthesis, methodological development, and collaborative research activities. Such contributions support the broader objectives of knowledge generation and evidence-based scientific progress.[5]

Publications

The publication portfolio includes peer-reviewed research articles indexed in recognized scholarly databases. Publication activity serves as an important indicator of research dissemination and academic communication. The documented body of work demonstrates ongoing participation in scientific discourse and contributes to the cumulative literature of biochemistry and allied disciplines.[1][6]

Research Impact

Citation performance provides one indicator of scholarly influence and research visibility. With more than two hundred citations recorded across multiple citing documents, the research outputs associated with Sohini Chakraborty have received measurable attention from the scientific community. Citation activity reflects the utilization, discussion, and acknowledgment of published findings by other researchers and institutions.[1][3]

Award Suitability

Eligibility for recognition through a Best Researcher Award may be evaluated using a combination of publication productivity, citation impact, research quality, academic integrity, and contribution to scientific advancement. Based on documented bibliometric indicators and continued engagement in biochemistry research, Sohini Chakraborty demonstrates characteristics commonly considered in academic recognition assessments. This assessment is descriptive in nature and does not represent an official award determination.[2][4]

Conclusion

Sohini Chakraborty’s academic profile reflects documented scholarly activity in biochemistry through publications, citations, and participation in scientific research. Bibliometric indicators, institutional affiliation, and research dissemination collectively support a profile of ongoing academic contribution. Recognition initiatives such as the World Science Awards provide a framework for highlighting researchers whose work contributes to the advancement of scientific knowledge and academic excellence.[1][2]

References

  1. Elsevier. (n.d.). Scopus Author Details: Sohini Chakraborty, Author ID 58709515200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58709515200
  2. World Science Awards. (n.d.). Academic Recognition and Research Excellence Programs.
    https://worldscienceawards.com/
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
  4. Moed, H. F. (2005). Citation Analysis in Research Evaluation. Springer.
  5. Biochemical research methodologies and interdisciplinary scientific applications. Biomedicine & Pharmacotherapy.

Gejla Toromani | Biochemistry | Research Excellence Award

Ms. Gejla Toromani | Biochemistry | Research Excellence Award

Miami University | United States

Ms. Gejla Toromani is an Honors College undergraduate researcher majoring in Biology with a premedical concentration at Miami University, with an expected graduation in 2026. Her interdisciplinary research spans virology, regenerative medicine, oncology, climate biology, and biomedical physics. She has contributed to at least five peer-reviewed publications in reputable international journals, including AIP Advances, Cureus, Annals of Plastic Surgery, and Medicina, and has presented her work at major national and international conferences. Her research experience includes a competitive summer fellowship at the University of Illinois Chicago, collaborative cancer database studies with multiple U.S. institutions, and long-term ecological analyses of Antarctic algae under climate stress. Through translational projects such as VR therapy for Parkinson’s disease and crisis mental health support, her work demonstrates clear societal relevance. Actively engaged in leadership and undergraduate research advocacy, she represents a strong emerging scholar with meaningful global and community impact.

Citation Metrics (Scopus)

40

30

20

10

0

Citations
0
h-index
0
Documents
2

Citations

h-index

Documents

Magdalena Koziol | Biochemistry | Research Excellence Award

Assist. Prof. Dr. Magdalena Koziol | Biochemistry | Research Excellence Award

Chinese Instistute for Brain Research | China

Dr. Magdalena Koziol is an Assistant Professor and Principal Investigator at the Chinese Institute for Brain Research (CIBR), China, where she leads an innovative research program at the intersection of developmental biology, epigenetics, and neuroscience. She completed her PhD in Developmental Biology at the University of Cambridge, UK, supported by a prestigious Wellcome Trust Studentship, with laboratory rotations under globally recognized leaders including Sir John B. Gurdon, Sarah Bray, and Azim Surani. Prior to this, she earned a BSc in Medical Genetics from the University of Leicester, UK, where she received two academic excellence awards, and previously undertook Physics studies at the University of Stuttgart, Germany. Dr. Koziol’s postdoctoral career includes highly competitive appointments with Sir John B. Gurdon at the Gurdon Institute, Antonio Giraldez at Yale University, and John Rinn at Harvard University and the Broad Institute. Her interdisciplinary background has helped shape a research portfolio focused on uncovering previously unknown chemical modifications of DNA and RNA and understanding their functional relevance in the vertebrate brain. Her groundbreaking discovery of methylated deoxyadenosine (m6dA) in vertebrate genomes, published in 2015, established a new field of study in epigenetic regulation and earned recognition from AAAS Science for excellence in scientific achievement. Her research has secured major competitive funding, including support from the Beijing Natural Science Foundation, the Koziol Laboratory core funding at CIBR, the BBSRC (UK), the Isaac Newton Trust, and the Human Frontiers Long-Term Fellowship program. She has also been recognized with distinguished honors, including an invitation to Buckingham Palace by Queen Elizabeth II. Through high-impact publications, international collaboration, and translational scientific vision, Dr. Koziol’s work contributes to advancing molecular neuroscience, with growing implications for understanding brain disorders and developing therapeutic strategies.

Profiles: ORCID

Featured Publications

Li, S., Zhang, S., Li, H., Yin, N., Yang, R., Zhang, Y., Koziol, M. J., & Faiola, F. (2025). Environmental UV filters threaten human neurodevelopment: Disruption of central and peripheral nervous system lineage commitment via WNT signaling dysregulation.

Feng, S., & Koziol, M. J. (2025). Unraveling brain complexity: From single-cell to spatial m6A technologies.

Feng, S., Tellaetxe-Abete, M., Zhang, Y., Peng, Y., Zhou, H., Dong, M., Larrea, E., Xue, L., Zhang, L., & Koziol, M. J. (2024). Single-cell discovery of m6A RNA modifications in the hippocampus.

Feng, S., Tellaetxe-Abete, M., Zhang, Y., Peng, Y., Zhou, H., Dong, M., Larrea, E., Xue, L., Zhang, L., & Koziol, M. J. (2023, December 13). Single-cell discovery of m6A RNA modifications in the hippocampus.

Wen, M.-H., Triana, H. B., Butler, R., Hu, H.-W., Dai, Y.-H., Lawrence, N., Hong, J.-J., Garrett, N., Jones-Green, R., Rawlins, E. L., & others. (2023). Deterministic nuclear reprogramming of mammalian nuclei to a totipotency-like state by amphibian meiotic oocytes for stem cell therapy in humans.

Azam Moosavi | Biochemistry | Best Researcher Award

Dr. Azam Moosavi | Biochemistry | Best Researcher Award

R&D lab Manager/supervisor of innovation center of SCARM(Stem Cell and Regenerative Medicine) from Tabriz University of Medical Sciences, Iran

Dr. Azam Moosavi is a dedicated and innovative biochemist specializing in beta-cell regeneration for the treatment of Type 1 diabetes. With a strong academic foundation and a passion for interdisciplinary research, she integrates molecular biology, regenerative medicine, and clinical biochemistry in her scientific work. Over her academic and professional career, she has developed a notable track record in research, mentorship, and laboratory management. Her research aims to translate scientific findings into real-world applications, especially for chronic diseases like diabetes. She has contributed to several peer-reviewed publications, presented at major international conferences, and co-authored a book chapter on bioactive peptides. Currently serving as R&D and Cell Culture Lab Manager at the Innovation Center of Stem Cells and Regenerative Medicine at Tabriz University of Medical Sciences, Dr. Moosavi is also actively involved in mentoring young researchers. With additional expertise in teaching, clinical laboratory operations, and scientific writing, she brings a multifaceted approach to biomedical research. Her work demonstrates both academic rigor and practical impact, and she is highly regarded for her contributions to translational medicine, epigenetics, and molecular diagnostics. Dr. Moosavi continues to strive toward scientific excellence, combining curiosity with applied innovation in pursuit of better health solutions.

Professional Profile

Education

Dr. Azam Moosavi’s academic journey reflects her deep commitment to biomedical sciences and health research. She earned her Ph.D. in Biochemistry from the Institute of Biochemistry and Biophysics (IBB) at the University of Tehran, where her thesis focused on beta-cell regeneration in Type 1 diabetes through pharmaceutical induction. Her Ph.D. was marked by an impressive GPA (3.7/4) and resulted in multiple scientific presentations and publications. Prior to that, she completed a Master of Public Health (MPH) in Health Management and Reform at Tehran University of Medical Sciences, focusing on strategic risk management in health systems. She also holds an M.Sc. in Biochemistry from Tarbiat Moallem University in Tehran, where she investigated alpha thalassemia genetics, leading to multiple congress presentations. Dr. Moosavi began her academic training with a Bachelor of Science in Clinical Laboratory Sciences from Mashhad University of Medical Sciences, followed by an Associate degree in the same field from Tehran University of Medical Sciences. Her academic record is consistent, with GPA scores ranging from 3.3 to 3.9, showcasing a solid grasp of theory and practice. These multidisciplinary qualifications equip her with a robust foundation for both laboratory research and healthcare innovation.

Professional Experience

Dr. Moosavi brings over two decades of experience spanning research, laboratory management, and academic instruction. Since March 2023, she has served as R&D and Cell Culture Lab Manager at the Innovation Center of Stem Cells and Regenerative Medicine (SCARM), Tabriz University of Medical Sciences. Here, she supervises experimental design, oversees lab operations, mentors postgraduates, and contributes to cutting-edge regenerative research. Prior to this role, Dr. Moosavi spent ten years teaching biochemistry laboratory courses to medical, dental, and pharmacy students at Alborz University of Medical Sciences. Her instruction emphasized clinical applications and hands-on skills, significantly enhancing student competency in diagnostics. Between 2005 and 2013, she managed clinical laboratories in various health centers and at Kasra Hospital in Karaj, where she was responsible for quality control, team supervision, and staff training across hematology, microbiology, and biochemistry divisions. In addition to her formal roles, she has led workshops in quality control and hematology testing, implemented risk management strategies, and participated in numerous clinical and academic projects. Her professional journey is characterized by leadership in education, hands-on expertise in diagnostics, and a drive to integrate innovative research with public health practice.

Research Interests

Dr. Moosavi’s research interests are centered on the intersection of molecular biology, regenerative medicine, and clinical diagnostics. Her primary focus is on beta-cell regeneration as a therapeutic strategy for Type 1 diabetes—a condition she explores through pharmaceutical, genetic, and immunological lenses. She is particularly interested in cell-based models, gene regulatory networks, and high-tech therapeutic interventions aimed at reversing or halting disease progression. Her passion for stem cell biology and regenerative therapies is reflected in her involvement with mesenchymal stem cell research and the use of exosomes in clinical settings. Beyond diabetes, she has contributed to projects involving autoimmune disorders, fertility research, cancer diagnostics, and infectious diseases like COVID-19. Her work also explores epigenetic regulation, as evidenced by a highly cited publication on the role of epigenetics in human diseases. In addition, Dr. Moosavi is eager to integrate new technologies into her research, including artificial intelligence (AI), next-generation sequencing (NGS), and gene editing techniques. This interdisciplinary approach allows her to not only study disease mechanisms at the molecular level but also develop actionable, personalized treatment strategies. She continuously expands her research portfolio with a strong commitment to innovation and translational impact.

Research Skills

Dr. Moosavi has cultivated a wide array of research skills that span molecular techniques, computational analysis, and laboratory management. She is proficient in essential molecular biology methods including PCR, ELISA, Western blotting, and routine clinical laboratory testing. Her expertise also includes cell culture, particularly in managing regenerative medicine labs, as well as conducting experiments on the apoptotic effects of compounds and stem cell secretome applications. In addition to wet-lab skills, she is experienced in data analysis and literature management using tools like GraphPad Prism, RevMan5, and EndNote. Her training in Good Clinical Practice (GCP) and Good Manufacturing Practice (GMP) principles supports her ability to implement and monitor high-quality standards in laboratory settings. Moreover, she is well-versed in risk management using Failure Mode and Effects Analysis (FMEA), which she has applied to improve safety and operational efficiency in academic laboratories. With intermediate proficiency in English and basic command of German and Azerbaijani, she is also equipped for international collaboration. Altogether, her technical and analytical competencies allow her to conduct research that is both scientifically rigorous and aligned with current regulatory standards.

Awards and Honors

Dr. Azam Moosavi has received several notable recognitions throughout her academic and professional journey. She secured third place nationally in the Ph.D. entrance exam for biochemistry at the University of Tehran, reflecting her strong academic standing. Her contributions to the field of molecular biology and regenerative medicine have been acknowledged at prestigious conferences, including the Best Poster Award at the 17th National and 8th International Congress of Biochemistry and Molecular Biology in 2023. Additionally, she was selected as the first presenter in the Young Researchers’ Section at the 15th International & 21st National Congress on Quality Improvement in Clinical Laboratories in 2024. Beyond academic accolades, Dr. Moosavi holds a patent related to lung cancer antibody production using nanopharmaceutical technology, underscoring her innovation in translational research. She also earned third position in the National Industrial Innovation Competition, further recognizing her role in applied scientific development. These honors validate her dedication to excellence, whether in academic research, laboratory innovation, or public health impact. Collectively, these awards demonstrate Dr. Moosavi’s significant contributions to biomedical science and affirm her as a rising leader in the fields of biochemistry and regenerative medicine.

Conclusion

Dr. Azam Moosavi emerges as a well-qualified candidate for the Best Researcher Award, with extensive contributions to biochemistry, regenerative medicine, and clinical laboratory science. Her academic credentials, professional experience, and interdisciplinary research projects collectively demonstrate excellence in both theoretical and applied science. Through her focus on beta-cell regeneration for Type 1 diabetes, Dr. Moosavi has tackled a major public health challenge using innovative and translational approaches. Her record includes numerous peer-reviewed publications, international presentations, patents, and awards, positioning her as a leader in her field. She has also played a key role in education and mentorship, nurturing the next generation of biomedical researchers. With solid research skills, an expanding network of collaborations, and a commitment to continuous learning, Dr. Moosavi has built a career marked by impact, growth, and forward-thinking science. Moving forward, she is poised to make even greater contributions through high-impact research, interdisciplinary teamwork, and international engagement. Her profile exemplifies the qualities that the Best Researcher Award seeks to honor: intellectual rigor, practical innovation, and a drive to improve human health through science.

Publications Top Notes

  1. Beta Cell Regeneration upon Magainin and Growth Hormone Treatment as a Possible Alternative to Insulin Therapy
    Journal: FEBS Open Bio, 2023
    Authors: Azam Moosavi, Razieh Yazdanparast

  2. Human Herpesvirus 6 Infection and Risk of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis
    Journal: Intervirology, 2022
    Author: Azam Moosavi

  3. A Systematic Review and Meta-Analysis on the Epidemiology, Causal Agents and Demographic Characteristics of Onychomycosis in Iran
    Journal: Medical Mycology, 2019
    Author: Azam Moosavi

  4. Environmental Exposure to Endotoxin and Its Health Outcomes: A Systematic Review
    Journal: Ecotoxicology and Environmental Safety, 2019
    Author: Azam Moosavi

  5. The Frequency of Fungi Isolated from the Skin and Hair of Asymptomatic Cats in Rural Area of Meshkin-shahr, Iran
    Journal: Journal de Mycologie Médicale, 2019
    Authors: A. Moosavi, R.D. Ghazvini, K. Ahmadikia, S.J. Hashemi, M. Geramishoar, M. Mohebali, M.S. Yekaninejad, H. Bakhshi, M. Khodabakhsh

  6. The Frequency and Importance of Common α-globin Gene Deletions among β-thalassemia Carriers in an Iranian Population
    Journal: Avicenna Journal of Medical Biotechnology, 2017
    Authors: A. Moosavi, A.M. Ardekani

  7. Role of Epigenetics in Biology and Human Diseases
    Journal: Iranian Biomedical Journal, 2016
    Author: Azam Moosavi

  8. Bioactive Peptides
    Publisher: CRC Press, 2021
    Author: Azam Moosavi

  9. Effect of Vitamin B6 Supplementation on Biochemical Values in Type 2 Diabetes Mellitus
    Conference: Congress on Quality Improvement in Clinical Laboratories, 2015
    Author: Azam Moosavi

 

ANDREA GOBBO | Biochemistry | Best Researcher Award

Ms. ANDREA GOBBO | Biochemistry | Best Researcher Award

Research Scientist at Sciensano, Belgium

Andrea Gobbo, MSc, is a research scientist specializing in health and environmental sciences, with over three years of experience in molecular biology. She holds an MSc in Chemical Sciences with a focus on biochemistry and molecular biology, graduating cum laude. Andrea has demonstrated expertise in developing and validating genomic methods such as qPCR and ddPCR for national and European Union (EU) projects related to antimicrobial resistance (AMR), genetically modified organisms (GMOs), and food/feed additives. Her contributions to scientific research are reflected in eight peer-reviewed publications, including one as the first author. In addition to research, Andrea actively mentors students in laboratory techniques and contributes to team-building activities, underscoring her commitment to collaboration and knowledge sharing. Her professional experience spans method validation, project management, and scientific communication, with proven skills in laboratory operations and data analysis. Fluent in French, English, and Dutch, Andrea is well-equipped to engage with diverse teams on global research initiatives. Her dedication to advancing health and environmental science makes her an exemplary candidate for recognition in her field.

Professional Profile

Education

Andrea Gobbo completed her Bachelor’s and Master’s degrees in Chemical Sciences at the Université Libre de Bruxelles. Her undergraduate studies, conducted from 2015 to 2019, included a thesis titled “Abundance of Chemical Elements in the Solar System,” highlighting her early interest in scientific inquiry. Graduating cum laude in 2021, Andrea’s Master’s program focused on biochemistry and molecular biology. During this time, she conducted a six-month internship for her Master’s thesis, where she explored the aggregation kinetics of amyloid beta peptide mutants related to Alzheimer’s disease. Her dedication to academic excellence is evident through her rigorous coursework and research, which provided her with a solid foundation in molecular biology techniques. This academic journey laid the groundwork for her transition into impactful professional roles in the field of health and environmental sciences.

Professional Experience

Andrea Gobbo’s professional career is marked by progressive roles at Sciensano, Belgium’s leading health and research institute. From 2022 to 2024, she served as a junior scientist, contributing to developing and validating qPCR and ddPCR methods for national and EU projects. Promoted to scientist in 2024, Andrea now leads molecular biology research for projects aimed at improving human, animal, and environmental health. Her responsibilities include drafting SOPs, mentoring students, and presenting findings at national scientific events. Andrea’s work spans numerous projects, including AMR gene detection in wastewater, GMO identification in food and feed, and DNA analysis for probiotics and vitamins. Her expertise in method validation and project management has been integral to these projects’ success. Additionally, her internship experiences at Sciensano and the Université Libre de Bruxelles further honed her technical and analytical skills in molecular biology.

Research Interests

Andrea Gobbo’s research interests lie at the intersection of molecular biology, health, and environmental sciences. She is particularly passionate about developing and validating genomic methods to address pressing global challenges, such as antimicrobial resistance (AMR) and food safety. Her work focuses on using innovative techniques, including qPCR, ddPCR, and whole-genome sequencing, to detect and quantify genetic markers in various samples, ranging from wastewater to food products. Andrea is also intrigued by applying molecular biology to monitor and control genetically modified organisms (GMOs) and pathogens in environmental and clinical settings. Her commitment to advancing public health through cutting-edge research drives her involvement in interdisciplinary projects that bridge science, policy, and societal needs.

Research Skills

Andrea Gobbo possesses a comprehensive skill set in molecular biology, including advanced techniques like qPCR, ddPCR, and multiplexing. Her expertise extends to DNA/RNA extraction, quantification, and sequencing preparation using state-of-the-art technologies such as Sanger, Illumina, and Oxford Nanopore. Andrea is adept at bacterial and fungal culture, DNA walking, agarose gel electrophoresis, and quality control methods like TapeStation analysis. Her experience in working under ISO 17025 accreditation ensures adherence to high-quality standards in laboratory practices. Beyond technical skills, Andrea excels in data analysis, problem-solving, and critical thinking, making her proficient in designing and validating complex genomic assays. She is also skilled in using bioinformatic tools like Primer3, BLAST, and laboratory instrument software, enhancing her ability to interpret and analyze genomic data effectively.

Awards and Honors

While specific awards and honors are not explicitly listed in her profile, Andrea Gobbo’s professional trajectory and achievements reflect a high standard of excellence. Graduating cum laude in her Master’s program demonstrates her dedication to academic success. Her rapid progression from a junior scientist to a lead scientist at Sciensano highlights her outstanding contributions to the field of molecular biology. Additionally, her selection to present at national scientific events and her role as a first author in a peer-reviewed publication underscore her recognition as a valuable researcher. These accomplishments position Andrea as a potential candidate for prestigious awards in health and environmental sciences.

Conclusion

Andrea Gobbo is a highly skilled and dedicated researcher whose work in molecular biology significantly contributes to health and environmental sciences. With a strong educational background, a robust publication record, and proven expertise in genomic method development, Andrea embodies the qualities of a leading scientist. Her ability to manage projects, mentor students, and collaborate effectively demonstrates her commitment to advancing scientific research and fostering teamwork. While further leadership in large-scale projects and greater international recognition could enhance her profile, Andrea’s achievements to date make her an exemplary candidate for the Best Researcher Award.

Publication Top Notes

  1. Development of a real-time PCR marker targeting a new unauthorized genetically modified microorganism producing protease identified by DNA walking
    Authors: MA Fraiture, A Gobbo, U Marchesi, D Verginelli, N Papazova, …
    Journal: International Journal of Food Microbiology
    Year: 2021
    Citation count: 13
  2. Development of a droplet digital PCR to monitor SARS-CoV-2 omicron variant BA.2 in wastewater samples
    Authors: LAE Van Poelvoorde, C Picalausa, A Gobbo, B Verhaegen, M Lesenfants, …
    Journal: Microorganisms
    Year: 2023
    Citation count: 5
  3. Development of a Taxon-Specific Real-Time PCR Method Targeting the Bacillus subtilis Group to Strengthen the Control of Genetically Modified Bacteria in …
    Authors: MA Fraiture, A Gobbo, N Papazova, NHC Roosens
    Journal: Fermentation
    Year: 2022
    Citation count: 5
  4. Pilot market surveillance of GMM contaminations in alpha-amylase food enzyme products: A detection strategy strengthened by a newly developed qPCR method targeting a GM …
    Authors: MA Fraiture, A Gobbo, C Guillitte, U Marchesi, D Verginelli, J De Greve, …
    Journal: Food Chemistry: Molecular Sciences
    Year: 2024
    Citation count: 2
  5. Development and validation of a ddPCR assay to detect and quantify tobacco DNA in smoke and smokeless tobacco and tobacco-free products
    Authors: MA Fraiture, A Gobbo, C Guillitte, S Barhdadi, C Gau, P Philipp, L Marmin, …
    Journal: Heliyon
    Year: 2024
    Citation count: 1
  6. Strategy to develop and validate digital droplet PCR methods for global antimicrobial resistance wastewater surveillance
    Authors: A Gobbo, MA Fraiture, L Van Poelvoorde, SCJ De Keersmaecker, …
    Journal: Water Environment Research
    Year: 2024
  7. Development of a reverse transcriptase digital droplet polymerase chain reaction-based approach for SARS-CoV-2 variant surveillance in wastewater
    Authors: LAE Van Poelvoorde, A Gobbo, SJD Nauwelaerts, B Verhaegen, …
    Journal: Water Environment Research
    Year: 2024
  8. Development of a Taxon-Specific Real-Time Polymerase Chain Reaction Method to Detect Trichoderma reesei Contaminations in Fermentation Products
    Authors: MA Fraiture, A Gobbo, N Papazova, NHC Roosens
    Journal: Fermentation
    Year: 2023

 

 

Dr. Florence Back | Biochemistry | Best Researcher Award

Dr. Florence Back | Biochemistry | Best Researcher Award

Doctorate at University of Lille, France

Florence Back is a distinguished biomaterials scientist and researcher specializing in bioadhesive and smart wound-healing technologies. Based in Strasbourg, France, she has made significant strides in developing innovative materials for medical applications, including hydrogels and electronic patches for therapeutic uses. Florence’s work is underpinned by advanced training in in vivo procedures and applied chemistry, making her well-versed in both the laboratory synthesis of biomaterials and preclinical surgical applications. Her research has been published in reputable journals, highlighting her commitment to advancing the fields of bioengineering and regenerative medicine. Florence’s research integrates expertise across biology, chemistry, and physics, emphasizing both material functionality and patient-centered applications. She has been involved in collaborative research at prestigious institutions, including CNRS Lille and UC Louvain, and is actively expanding her interdisciplinary contributions to wound care, tissue repair, and bioengineering.

Professional Profile

Education

Florence holds a Ph.D. in Biomaterials from UNISTRA Strasbourg, completed in 2022, where she focused on the synthesis and development of bioadhesives based on gelatin and catechol. This work involved extensive research into the formulation, spectroscopic characterization, and rheological analysis of these bioadhesives. Her doctoral studies were preceded by two specialized master’s degrees, both from UNISTRA Strasbourg, in supramolecular and macromolecular chemistry, completed in 2020 and 2019, respectively. Florence’s master’s education covered advanced techniques in organic and polymer synthesis, including the creation of fluorescent molecules and polymers with unique biochemical properties. Her academic journey includes a series of certifications in in vivo procedures from CNRS Lille, where she developed critical surgical skills required for research involving animal models. Florence’s education has been integral in building her comprehensive understanding of biomaterials and in vivo applications, positioning her as a skilled researcher in medical and chemical sciences.

Professional Experience

Florence’s professional experience includes postdoctoral research and engineering roles focused on advancing biomaterial applications in medicine. Currently, she is a postdoctoral researcher at UC Louvain in Belgium, working on the AI-SWEEP-2 project, which involves the synthesis of electronic patches for smart bandages intended for human use. Prior to this, she served as a biomaterials engineer at CNRS Lille, where she contributed to the ANR Gskin project, focusing on synthesizing and characterizing hydrogels doped with extracellular vesicles for diabetic wound healing. From 2020 to 2022, during her Ph.D. at the Dental Faculty of Strasbourg, Florence specialized in the synthesis of bioadhesives based on gelatin and catechol, marking the beginning of her notable contributions to biomaterials science. These roles have allowed her to develop an integrated approach to material synthesis, characterization, and biological application, emphasizing her commitment to innovation in therapeutic and regenerative materials.

Research Interests

Florence’s research interests center on biomaterials, bioadhesives, and smart wound-healing technologies. Her primary focus is the development and synthesis of bioadhesive hydrogels, which hold promise in tissue repair and regenerative medicine. Additionally, her work extends to smart bandages, integrating electronic patches for wound monitoring and therapeutic delivery, aimed at improving patient outcomes in wound care. She is also interested in the extraction and application of extracellular vesicles in biomaterials, with specific attention to their role in promoting cellular viability and tissue regeneration. Florence’s research leverages a multidisciplinary approach, combining chemistry, biology, and materials science to create innovative solutions that bridge the gap between synthetic materials and biological functions. Her commitment to research that addresses clinical challenges underscores her dedication to advancing biomaterials for direct medical applications.

Research Skills

Florence’s research skills encompass a wide range of laboratory and analytical techniques, particularly in chemistry, biology, and materials science. She is proficient in organic and polymer synthesis, including gel formulation and the development of bioadhesive materials from gelatin, chitosan, and silk hydrogels. Her technical skills include chromatography, spectroscopy (NMR, IR, UV-Vis), and nanoparticle tracking analysis, which she applies in the characterization of synthesized materials. Florence is also skilled in in vivo procedures, certified for surgeries and techniques on various animal models, such as vascular catheterization, cerebral ischemia, and renal grafting. Additionally, her experience extends to cell culture, viability testing, and supervising research protocols. Florence’s ability to conduct comprehensive material characterization combined with her surgical training in vivo highlights her versatility and readiness to bridge laboratory research with applied medical sciences.

Awards and Honors

Florence has achieved various recognitions that reflect her dedication to research excellence in biomaterials. Her doctoral research at UNISTRA Strasbourg earned her acclaim for creating bioadhesive formulations with potential applications in tissue engineering and wound care. Her work has been published in notable journals, including Frontiers in Materials and Gels, indicating her research’s value to the academic and clinical communities. Florence’s role in collaborative projects, such as the ANR Gskin and AI-SWEEP-2, highlights her contributions to interdisciplinary research initiatives aimed at developing innovative therapeutic technologies. Additionally, her certifications in in vivo procedures from CNRS Lille are a testament to her commitment to ethical and skillful research practices. Florence’s career trajectory, marked by research achievements and collaborative contributions, positions her as a promising candidate for awards in scientific innovation and applied biomaterials.

Conclusion

Florence Back demonstrates strong candidacy for a “Best Researcher Award” due to her advanced technical skills in biomaterials, substantial in vivo training, and impactful research in bioadhesives and smart bandage technologies. By addressing minor language skills and pursuing independent research initiatives, she could amplify her contributions and influence in the field.

Publication Top Notes

  1. Optimization of the Elasticity and Adhesion of Catechol- or Dopamine-Loaded Gelatin Gels under Oxidative Conditions
    • Authors: F. Back, E. Mathieu, C. Betscha, Y. Arntz, V. Ball
    • Journal: Gels
    • Year: 2022
    • Volume & Issue: 8(4), Article 210
    • Citations: 7
    • Open Access: Yes
  2. Influence of the NaIO₄ Concentration on the Gelation and the Adhesive Strength of Pyrocatechol/Pyrogallol Containing Gelatin Hydrogels
    • Authors: F. Back, V. Ball, Y. Arntz
    • Journal: Frontiers in Materials
    • Year: 2021
    • Volume & Article: 8, Article 671451
    • Citations: 4
    • Open Access: Yes